First-in-human study of ABBV-400, a novel c-Met-targeting antibody-drug conjugate, in advanced solid tumors: Results in colorectal cancer

被引：0
|
作者：
Sharma, Manish
Strickler, John H.
Sommerhalder, David
Kuboki, Yasutoshi
Perets, Ruth
Cohen, Jonathan
Raimbourg, Judith
Nakajima, Takako Eguchi
Yamamoto, Noboru
Cruz-Correa, Marcia
O'Neil, Bert
Ghiringhelli, Francois
Raghav, Kanwal Pratap Singh
Li, Rui
Thiele, Gladys Morrison
Aristide, Martha Raluca Neagu
Freise, Kevin Jay
de Almeida, Carla Biesdorf
Vasilopoulos, Athanasios
Powderly, John D., II
机构：
[1] START Midwest, Grand Rapids, MI USA
[2] Duke Univ, Sch Med, Durham, NC USA
[3] NEXT Oncol, San Antonio, TX USA
[4] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[5] Rambam Med Ctr, Haifa, Israel
[6] Technion Israel Inst Technol, Haifa, Israel
[7] Hebrew Univ Jerusalem, Sharett Inst Oncol, Wohl Inst Translat Med, Hadassah Med Ctr,Hadassh Hebrew Univ Med Ctr, Jerusalem, Israel
[8] Ctr Rene Gauducheau, Insit Cancerol Ouest, St Herblain, France
[9] Kyoto Univ, Grad Sch Med, Kyoto, Japan
[10] Natl Canc Ctr, Tokyo, Japan
[11] Univ Puerto Rico, Med Sci Campus, San Juan, PR USA
[12] Pan Amer Ctr Oncol Trials, San Juan, PR USA
[13] Community Hlth Canc Ctr North, Indianapolis, IN USA
[14] Ctr Georges Francois Leclerc, Dijon, France
[15] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[16] AbbVie Inc, N Chicago, IL USA
[17] Carolina Biooncol Inst, Huntersville, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3515
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Developing a novel doppel-targeting antibody-drug conjugate (ADC) for solid cancer
    Lee, Ha Kyeong
    Kim, Byoungmo
    Kweon, Seho
    Choi, Jeong Uk
    Kim, Sang Yoon
    Byun, Youngro
    CANCER RESEARCH, 2023, 83 (07)
  • [32] A first-in-human trial of the integrin beta-6-targeted antibody-drug conjugate, SGN-B6A, in patients with advanced solid tumors
    Calvo, E.
    Hollebecque, A.
    Dowlati, A.
    Piha-Paul, S. A.
    Galvao, V.
    Lopez, J.
    Sehgal, K.
    Bockorny, B.
    Braiteh, F.
    Peters, S.
    Sanborn, R. E.
    Zhou, P.
    Nazarenko, N.
    Patnaik, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S613 - S613
  • [33] ABBV-399, a c-Met Antibody-Drug Conjugate that Targets Both MET-Amplified and c-Met-Overexpressing Tumors, Irrespective of MET Pathway Dependence
    Wang, Jieyi
    Anderson, Mark G.
    Oleksijew, Anatol
    Vaidya, Kedar S.
    Boghaert, Erwin R.
    Tucker, Lora
    Zhang, Qian
    Han, Edward K.
    Palma, Joann P.
    Naumovski, Louie
    Reilly, Edward B.
    CLINICAL CANCER RESEARCH, 2017, 23 (04) : 992 - 1000
  • [34] A first-in-human (FIH) phase 1 study of SHR-A1921, a TROP-2 targeted antibody-drug conjugate (ADC), in patients with advanced solid tumors
    Wang, Jie
    Wu, Lin
    Song, Zhengbo
    Li, Xingya
    Liu, Caigang
    Liu, Tianshu
    Wu, Yiwen
    Zhang, Ze
    Wang, Shuni
    CANCER RESEARCH, 2023, 83 (08)
  • [35] First-in-human study of ABBV-011, a seizure-related homolog protein 6 (SEZ6)-targeting antibody-drug conjugate, in patients with small cell lung cancer
    Morgensztern, Daniel
    Ready, Neal E.
    Johnson, Melissa Lynne
    Dowlati, Afshin
    Choudhury, Noura J.
    Carbone, David Paul
    Schaefer, Eric S.
    Arnold, Susanne M.
    Puri, Sonam
    Piotrowska, Zofia
    Hegde, Aparna Madhukeshwar
    Chiang, Anne C.
    Iams, Wade Thomas
    Tolcher, Anthony W.
    Nosaki, Kaname
    Zha, Jiuhong
    Li, Rui
    Hingorani, Pooja
    Jeng, Edwin E.
    Furqan, Muhammad
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer
    Morgensztern, Daniel
    Ready, Neal
    Johnson, Melissa L.
    Dowlati, Afshin
    Choudhury, Noura
    Carbone, David P.
    Schaefer, Eric
    Arnold, Susanne M.
    Puri, Sonam
    Piotrowska, Zofia
    Hegde, Aparna
    Chiang, Anne C.
    Iams, Wade
    Tolcher, Anthony
    Nosaki, Kaname
    Kozuki, Toshiyuki
    Li, Tianhong
    Santana-Davila, Rafael
    Akamatsu, Hiroaki
    Murakami, Haruyasu
    Yokouchi, Hiroshi
    Wang, Song
    Zha, Jiuhong
    Li, Rui
    Robinson, Randy R.
    Hingorani, Pooja
    Jeng, Edwin E.
    Furqan, Muhammad
    CLINICAL CANCER RESEARCH, 2024, 30 (22) : 5042 - 5052
  • [37] A novel MET antibody-drug conjugate based combination therapy to overcome colorectal cancer plasticity and drug resistance
    Subramanian, Shraddha
    Posey, Tressie A.
    Jacob, Joan
    Aldana, Adela
    Carmon, Kendra S.
    CANCER RESEARCH, 2024, 84 (06)
  • [38] First-in-human study of ABBV-514 as monotherapy and in combination with budigalimab in patients with advanced solid tumors
    Babu, S.
    Kondo, S.
    Ammakkanavar, N.
    Spira, A. I.
    Perets, R.
    Doi, T.
    Bar, J.
    Vandross, A.
    Sommerhalder, D.
    Nikolic, V.
    Tribouley, C.
    Atluri, H.
    Hong, J.
    Paustian, A.
    Leibman, R.
    Powderly, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S647 - S648
  • [39] First in human dose-escalation trial with the c-MET targeting antibody-drug conjugate BYON3521
    Kotecki, N.
    van Herpen, C. M. L.
    Curigliano, C.
    Hendriks, M.
    Vermaas, T. C.
    Corrigan, L.
    Belli, C.
    Jungels, C.
    Desar, I. M. E.
    Koper, N. P.
    Schellens, J. H. M.
    Banerji, U.
    CANCER RESEARCH, 2023, 83 (08)
  • [40] First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors
    Zhang, Jian
    Du, Yiqun
    Meng, Yanchun
    Liu, Xiaojun
    Mu, Yuxin
    Liu, Yunpeng
    Shi, Yehui
    Wang, Jufeng
    Zang, Aimin
    Gu, Shanzhi
    Liu, Tianshu
    Zhou, Huan
    Guo, Hongqian
    Xiang, Silong
    Zhang, Xialu
    Wu, Suqiong
    Qi, Huanhuan
    Li, Mengke
    Hu, Xichun
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
12345